{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:04:31Z","timestamp":1790949871424,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1ZIAAI001102-11"],"award-info":[{"award-number":["1ZIAAI001102-11"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-021-00968-y","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T16:15:57Z","timestamp":1634832957000},"page":"1398-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons"],"prefix":"10.1038","volume":"6","author":[{"given":"Durbadal","family":"Ojha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton W.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-7422","authenticated-orcid":false,"given":"Jacqueline M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-6553","authenticated-orcid":false,"given":"Catherine Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-6035","authenticated-orcid":false,"given":"Charles D.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Tawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-0757","authenticated-orcid":false,"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn L.","family":"Haigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-7249","authenticated-orcid":false,"given":"Karin E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"968_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1128\/CMR.7.1.89","volume":"7","author":"CH Calisher","year":"1994","unstructured":"Calisher, C. H. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7, 89\u2013116 (1994).","journal-title":"Clin. Microbiol. Rev."},{"key":"968_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/088307389901400101","volume":"14","author":"RS Rust","year":"1999","unstructured":"Rust, R. S. et al. Topical review: La Crosse and other forms of California encephalitis. J. Child. Neurol. 14, 1\u201314 (1999).","journal-title":"J. Child. Neurol."},{"key":"968_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/oxfordjournals.aje.a120512","volume":"81","author":"WH Thompson","year":"1965","unstructured":"Thompson, W. H., Kalfayan, B. & Anslow, R. O. Isolation of California encephalitis group virus from a fatal human illness. Am. J. Epidemiol. 81, 245\u2013253 (1965).","journal-title":"Am. J. Epidemiol."},{"key":"968_CR4","first-page":"225","volume":"123","author":"WH Thompson","year":"1983","unstructured":"Thompson, W. H. & Gundersen, C. B. La Crosse encephalitis: occurrence of disease and control in a suburban area. Prog. Clin. Biol. Res. 123, 225\u2013236 (1983).","journal-title":"Prog. Clin. Biol. Res."},{"key":"968_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3201\/eid2105.141992","volume":"21","author":"AJ Lambert","year":"2015","unstructured":"Lambert, A. J. et al. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA. Emerg. Infect. Dis. 21, 833\u2013836 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"968_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4269\/ajtmh.1975.24.999","volume":"24","author":"LW Gauld","year":"1975","unstructured":"Gauld, L. W., Yuill, T. M., Hanson, R. P. & Sinha, S. K. Isolation of La Crosse virus (California encephalitis group) from the chipmunk (Tamias striatus), an amplifier host. Am. J. Trop. Med. Hyg. 24, 999\u20131005 (1975).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"968_CR7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/v11090794","volume":"11","author":"AB Evans","year":"2019","unstructured":"Evans, A. B. & Peterson, K. E. Throw out the map: neuropathogenesis of the globally expanding California serogroup of orthobunyaviruses. Viruses 11, 794 (2019).","journal-title":"Viruses"},{"key":"968_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01313746","volume":"108","author":"GD Baldridge","year":"1989","unstructured":"Baldridge, G. D., Beaty, B. J. & Hewlett, M. J. Genomic stability of La Crosse virus during vertical and horizontal transmission. Arch. Virol. 108, 89\u201399 (1989).","journal-title":"Arch. Virol."},{"key":"968_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/INF.0b013e31821c922c","volume":"30","author":"JE McJunkin","year":"2011","unstructured":"McJunkin, J. E. et al. Safety and pharmacokinetics of ribavirin for the treatment of La Crosse encephalitis. Pediatr. Infect. Dis. J. 30, 860\u2013865 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"968_CR10","unstructured":"Centers for Disease Control and Prevention. La Crosse encephalitis (2018); https:\/\/www.cdc.gov\/lac\/index.html"},{"key":"968_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/JVI.02327-10","volume":"86","author":"RS Bennett","year":"2012","unstructured":"Bennett, R. S. et al. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys. J. Virol. 86, 420\u2013426 (2012).","journal-title":"J. Virol."},{"key":"968_CR12","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1128\/JVI.01866-14","volume":"88","author":"KG Taylor","year":"2014","unstructured":"Taylor, K. G. et al. Age-dependent myeloid dendritic cell responses mediate resistance to La Crosse virus-induced neurological disease. J. Virol. 88, 11070\u201311079 (2014).","journal-title":"J. Virol."},{"key":"968_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0836-3","volume":"14","author":"CW Winkler","year":"2017","unstructured":"Winkler, C. W. et al. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse virus infection in mice. J. Neuroinflammation 14, 62 (2017).","journal-title":"J. Neuroinflammation"},{"key":"968_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00401-015-1433-0","volume":"130","author":"CW Winkler","year":"2015","unstructured":"Winkler, C. W., Race, B., Phillips, K. & Peterson, K. E. Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion. Acta Neuropathol. 130, 233\u2013245 (2015).","journal-title":"Acta Neuropathol."},{"key":"968_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2013.02.013","volume":"38","author":"P Mukherjee","year":"2013","unstructured":"Mukherjee, P., Woods, T. A., Moore, R. A. & Peterson, K. E. Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity 38, 705\u2013716 (2013).","journal-title":"Immunity"},{"key":"968_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3201\/eid2504.181016","volume":"25","author":"AB Evans","year":"2019","unstructured":"Evans, A. B., Winkler, C. W. & Peterson, K. E. Differences in neuropathogenesis of encephalitic California serogroup viruses. Emerg. Infect. Dis. 25, 728\u2013738 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"968_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1356-5","volume":"15","author":"BE Dawes","year":"2018","unstructured":"Dawes, B. E. et al. Human neural stem cell-derived neuron\/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines. J. Neuroinflammation 15, 315 (2018).","journal-title":"J. Neuroinflammation"},{"key":"968_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1614-1","volume":"16","author":"CW Winkler","year":"2019","unstructured":"Winkler, C. W. et al. Neuronal maturation reduces the type I IFN response to orthobunyavirus infection and leads to increased apoptosis of human neurons. J. Neuroinflammation 16, 229 (2019).","journal-title":"J. Neuroinflammation"},{"key":"968_CR19","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1128\/JVI.00140-12","volume":"86","author":"BS Hollidge","year":"2012","unstructured":"Hollidge, B. S. et al. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J. Virol. 86, 7988\u20138001 (2012).","journal-title":"J. Virol."},{"key":"968_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrmicro3332","volume":"12","author":"RE Elliott","year":"2014","unstructured":"Elliott, R. E. Orthobunyaviruses: recent genetic and structural insights. Nat. Rev. Microbiol. 12, 673\u2013685 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"968_CR21","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/JVI.01492-10","volume":"85","author":"LT Lin","year":"2011","unstructured":"Lin, L. T. et al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein\u2013glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol. 85, 4386\u20134398 (2011).","journal-title":"J. Virol."},{"key":"968_CR22","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1128\/AAC.00356-07","volume":"51","author":"BB Gowen","year":"2007","unstructured":"Gowen, B. B. et al. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. Antimicrob. Agents Chemother. 51, 3168\u20133176 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"968_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbamcr.2012.01.007","volume":"1823","author":"T Sugawara","year":"2012","unstructured":"Sugawara, T. et al. PKC\u03b4 and \u03b5 regulate the morphological integrity of the ER\u2013Golgi intermediate compartment (ERGIC) but not the anterograde and retrograde transports via the Golgi apparatus. Biochim. Biophys. Acta 1823, 861\u2013875 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"968_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1124\/jpet.107.124669","volume":"322","author":"D Zhang","year":"2007","unstructured":"Zhang, D., Anantharam, V., Kanthasamy, A. & Kanthasamy, A. G. Neuroprotective effect of protein kinase C\u03b4 inhibitor rottlerin in cell culture and animal models of Parkinson\u2019s disease. J. Pharmacol. Exp. Ther. 322, 913\u2013922 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"968_CR25","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1128\/JVI.76.23.12200-12210.2002","volume":"76","author":"SR Gerrard","year":"2002","unstructured":"Gerrard, S. R. & Nichol, S. T. Characterization of the Golgi retention motif of Rift Valley Fever virus GN glycoprotein. J. Virol. 76, 12200\u201312210 (2002).","journal-title":"J. Virol."},{"key":"968_CR26","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1111\/j.1462-5822.2008.01184.x","volume":"10","author":"J Fontana","year":"2008","unstructured":"Fontana, J. et al. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell. Microbiol. 10, 2012\u20132028 (2008).","journal-title":"Cell. Microbiol."},{"key":"968_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1006\/viro.1996.0336","volume":"220","author":"K Bupp","year":"1996","unstructured":"Bupp, K., Stillmock, K. & Gonz\u00e1lez-Scarano, F. Analysis of the intracellular transport properties of recombinant La Crosse virus glycoproteins. Virology 220, 485\u2013490 (1996).","journal-title":"Virology"},{"key":"968_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0042-6822(84)90215-0","volume":"137","author":"Y Eshita","year":"1984","unstructured":"Eshita, Y. & Bishop, D. H. The complete sequence of the M RNA of snowshoe hare bunyavirus reveals the presence of internal hydrophobic domains in the viral glycoprotein. Virology 137, 227\u2013240 (1984).","journal-title":"Virology"},{"key":"968_CR29","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","unstructured":"Bertolotti-Ciarlet, A. et al. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 79, 6152\u20136161 (2005).","journal-title":"J. Virol."},{"key":"968_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1743-422X-2-42","volume":"2","author":"S Haferkamp","year":"2005","unstructured":"Haferkamp, S. et al. Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins. Virol. J. 2, 42 (2005).","journal-title":"Virol. J."},{"key":"968_CR31","first-page":"746","volume":"55","author":"MC Srivastava","year":"1967","unstructured":"Srivastava, M. C., Singh, S. W. & Tewari, J. P. Anthelmintic activity of Mallotus philippinensis-kambila powder. Ind. J. Med. Res. 55, 746\u2013748 (1967).","journal-title":"Ind. J. Med. Res."},{"key":"968_CR32","first-page":"2178","volume":"6","author":"J Su","year":"2016","unstructured":"Su, J. et al. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells. Am. J. Cancer Res. 6, 2178\u20132191 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"968_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0304-4165(02)00514-7","volume":"1620","author":"R Ishii","year":"2003","unstructured":"Ishii, R. et al. Inhibition of lipopolysaccharide-induced pro-inflammatory cytokine expression via suppression of nuclear factor-kappaB activation by Mallotus japonicus phloroglucinol derivatives. Biochim. Biophys. Acta 1620, 108\u2013118 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"968_CR34","doi-asserted-by":"publisher","first-page":"742936","DOI":"10.1155\/2009\/742936","volume":"2009","author":"E Maioli","year":"2009","unstructured":"Maioli, E. et al. Rottlerin inhibits ROS formation and prevents NFkappaB activation in MCF-7 and HT-29 cells. J. Biomed. Biotechnol. 2009, 742936 (2009).","journal-title":"J. Biomed. Biotechnol."},{"key":"968_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1248\/bpb.32.631","volume":"32","author":"SF Zaidi","year":"2009","unstructured":"Zaidi, S. F. et al. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Biol. Pharm. Bull. 32, 631\u2013636 (2009).","journal-title":"Biol. Pharm. Bull."},{"key":"968_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","volume":"199","author":"M Gschwendt","year":"1994","unstructured":"Gschwendt, M. et al. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199, 93\u201398 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"968_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20070797","volume":"408","author":"J Bain","year":"2007","unstructured":"Bain, J. et al. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297\u2013315 (2007).","journal-title":"Biochem. J."},{"key":"968_CR38","doi-asserted-by":"publisher","first-page":"37986","DOI":"10.1074\/jbc.M105073200","volume":"276","author":"SP Soltoff","year":"2001","unstructured":"Soltoff, S. P. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J. Biol. Chem. 276, 37986\u201337992 (2001).","journal-title":"J. Biol. Chem."},{"key":"968_CR39","doi-asserted-by":"publisher","first-page":"e44733","DOI":"10.1371\/journal.pone.0044733","volume":"7","author":"L Lei","year":"2012","unstructured":"Lei, L., Li, Z. & Zhong, G. Rottlerin-mediated inhibition of Chlamydia trachomatis growth and uptake of sphingolipids is independent of p38-regulated\/activated protein kinase (PRAK). PLoS ONE 7, e44733 (2012).","journal-title":"PLoS ONE"},{"key":"968_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1083\/jcb.87.3.783","volume":"87","author":"L K\u00e4\u00e4ri\u00e4inen","year":"1980","unstructured":"K\u00e4\u00e4ri\u00e4inen, L. et al. Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins. J. Cell Biol. 87, 783\u2013791 (1980).","journal-title":"J. Cell Biol."},{"key":"968_CR41","doi-asserted-by":"publisher","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","volume":"177","author":"SNY Yang","year":"2020","unstructured":"Yang, S. N. Y. et al. The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer. Antiviral Res. 177, 104760 (2020).","journal-title":"Antiviral Res."},{"key":"968_CR42","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.3390\/cells9092100","volume":"9","author":"DA Jans","year":"2020","unstructured":"Jans, D. A. & Wagstaff, K. M. Ivermectin as a broad-spectrum host-directed antiviral: the real deal? Cells 9, 2100 (2020).","journal-title":"Cells"},{"key":"968_CR43","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AAC.33.11.2009","volume":"33","author":"LF Cassidy","year":"1989","unstructured":"Cassidy, L. F. & Patterson, J. L. Mechanism of La Crosse virus inhibition by ribavirin. Antimicrob. Agents Chemother. 33, 2009\u20132011 (1989).","journal-title":"Antimicrob. Agents Chemother."},{"key":"968_CR44","first-page":"9","volume":"2","author":"DR Smith","year":"2010","unstructured":"Smith, D. R. et al. Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae. Virus Adapt. Treat. 2, 9\u201320 (2010).","journal-title":"Virus Adapt. Treat."},{"key":"968_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2019.04.002","volume":"167","author":"J Huchtingab","year":"2019","unstructured":"Huchtingab, J. et al. Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir). Antiviral Res. 167, 1\u20135 (2019).","journal-title":"Antiviral Res"},{"key":"968_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich, J. & Langford, D. et al. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol. Biol. 1078, 9\u201321 (2013).","journal-title":"Methods Mol. Biol."},{"key":"968_CR47","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ajpath.2011.04.011","volume":"179","author":"NB Butchi","year":"2010","unstructured":"Butchi, N. B. et al. TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS. Am. J. Pathol. 179, 783\u2013794 (2010).","journal-title":"Am. J. Pathol."},{"key":"968_CR48","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.drudis.2019.09.019","volume":"24","author":"R Huang","year":"2019","unstructured":"Huang, R. et al. The NCATS Pharmaceutical Collection: a 10-year update. Drug Discov. Today 24, 2341\u20132349 (2019).","journal-title":"Drug Discov. Today"},{"key":"968_CR49","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1128\/JVI.02934-15","volume":"90","author":"TA Woods","year":"2016","unstructured":"Woods, T. A., Du, M., Carmody, A. & Peterson, K. E. Neuropeptide Y negatively influences monocyte recruitment to the central nervous system during retrovirus infection. J. Virol. 90, 2783\u20132793 (2016).","journal-title":"J. Virol."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-021-00968-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-021-00968-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-021-00968-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:54:59Z","timestamp":1733957699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-021-00968-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1038\/s41564-021-00968-y","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}